View More View Less
  • 1 Semmelweis Egyetem, Általános Orvostudományi Kar II. Belgyógyászati Klinika Budapest Szentkirályi u. 46. 1088
  • | 2 Semmelweis Egyetem, Általános Orvostudományi Kar Családorvosi Tanszék Budapest
  • | 3 Semmelweis Egyetem, Általános Orvostudományi Kar Dietetikai és Táplálkozástudományi Tanszék Budapest
  • | 4 Magyar Tudományos Akadémia–Semmelweis Egyetem Molekuláris Medicina Kutatócsoport Budapest
  • | 5 Semmelweis Egyetem, Általános Orvostudományi Kar Budapest
Open access

Az átmeneti, illetve a tartós hyperglykaemia következménye a sejten belüli reaktív oxigéngyökök mellett a reaktív aldehidek felszaporodása. A reaktív aldehidek kóroki tényezőként szerepelhetnek a cukorbetegség késői szövődményeinek kialakulásában. Ezen csoportból kiemelkedő jelentőséggel bír a glükózfüggő α-dikarbonil, a metilglioxál. Elsőként cukorbetegségben igazolták a metilglioxál sejten belüli felhalmozódását és a szérumszint emelkedését. A felhalmozódó metilglioxál káros hatással bír a hasnyálmirigy β-sejtjeinek inzulintermelésére, a fehérjék és nukleinsavak működésére, valamint az egyik legfontosabb prekurzora a késői glikációs végtermékeknek (advanced glycation end-products). A metilglioxál-akkumuláció elleni védelmet jelentő katabolikus rendszer, a glioxaláz enzimrendszer minden emlőssejtben megtalálható. Jelen közlemény áttekintést ad a metilglioxál anyagcseréjéről normális, valamint hyperglykaemiás körülmények között, és tárgyalja a metilglioxál szerepét a diabeteses késői, microvascularis szövődmények kórélettanában. Orv. Hetil., 2012, 153, 574–585.

  • Marfella, R., Quagliaro, L., Nappo, F., et al.: Acute hyperglycemia induces an oxidative stress in healthy subjects. J. Clin. Invest., 2001, 108, 635–636.

    Nappo F. , 'Acute hyperglycemia induces an oxidative stress in healthy subjects ' (2001 ) 108 J. Clin. Invest. : 635 -636.

    • Search Google Scholar
  • Beisswenger, P. J., Howell, S. K., Nelson, R. G., et al.: Alpha-oxoaldehyde metabolism and diabetic complications. Biochem. Soc. Trans., 2003, 31, 1358–1363.

    Nelson R. G. , 'Alpha-oxoaldehyde metabolism and diabetic complications ' (2003 ) 31 Biochem. Soc. Trans. : 1358 -1363.

    • Search Google Scholar
  • Turk, Z.: Glycotoxines, carbonyl stress and relevance to diabetes and its complications. Physiol. Res., 2010, 59, 147–156.

    Turk Z. , 'Glycotoxines, carbonyl stress and relevance to diabetes and its complications ' (2010 ) 59 Physiol. Res. : 147 -156.

    • Search Google Scholar
  • Thornalley, P. J.: The glyoxalase system in health and disease. Mol. Aspects Med., 1993, 14, 287–371.

    Thornalley P. J. , 'The glyoxalase system in health and disease ' (1993 ) 14 Mol. Aspects Med. : 287 -371.

    • Search Google Scholar
  • Kalapos, M. P.: Methylglyoxal and glucose metabolism: a historical perspective and future avenues for research. Drug Metabol. Drug Interact., 2008, 23, 69–91.

    Kalapos M. P. , 'Methylglyoxal and glucose metabolism: a historical perspective and future avenues for research ' (2008 ) 23 Drug Metabol. Drug Interact. : 69 -91.

    • Search Google Scholar
  • Leoncini, G.: The role of alpha-ketoaldehydes in biological systems. Ital. J. Biochem., 1979, 28, 285–294.

    Leoncini G. , 'The role of alpha-ketoaldehydes in biological systems ' (1979 ) 28 Ital. J. Biochem. : 285 -294.

    • Search Google Scholar
  • Kozarich, J. W., Deegan, J. L.: 7-methylguanosine-dependent inhibition of globin mRNA translation by methylglyoxal. J. Biol. Chem., 1979, 254, 9345–9348.

    Deegan J. L. , '7-methylguanosine-dependent inhibition of globin mRNA translation by methylglyoxal ' (1979 ) 254 J. Biol. Chem. : 9345 -9348.

    • Search Google Scholar
  • Vander Jagt, D. L.: Methylglyoxal, diabetes mellitus and diabetic complication. Drug Metabol. Drug Interact., 2008, 23, 93–124.

    Jagt D. L. , 'Methylglyoxal, diabetes mellitus and diabetic complication ' (2008 ) 23 Drug Metabol. Drug Interact. : 93 -124.

    • Search Google Scholar
  • Fleming, H. T., Humpert, P. M., Nawroth, P. P., et al.: Reactive metabolites and AGE/RAGE-mediated cellular dysfunction affect the aging process – a mini review. Gerontology, 2011, 57, 435–443.

    Nawroth P. P. , 'Reactive metabolites and AGE/RAGE-mediated cellular dysfunction affect the aging process – a mini review ' (2011 ) 57 Gerontology : 435 -443.

    • Search Google Scholar
  • Phillips, S., Thornalley, P. J.: The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur. J. Biochem., 1993, 212, 101–105.

    Thornalley P. J. , 'The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal ' (1993 ) 212 Eur. J. Biochem. : 101 -105.

    • Search Google Scholar
  • Ponces Freire, A., Ferreira, A., Gomes, R., et al.: Anti-glycation defences in yeast. Biochem. Soc. Trans., 2003, 31, 1409–1412.

    Gomes R. , 'Anti-glycation defences in yeast ' (2003 ) 31 Biochem. Soc. Trans. : 1409 -1412.

  • Cooper, R. A., Anderson, A.: The formation and catabolism of methylglyoxal during glycolysis in Escherichia coli. FEBS Lett., 1970, 11, 273–276.

    Anderson A. , 'The formation and catabolism of methylglyoxal during glycolysis in Escherichia coli ' (1970 ) 11 FEBS Lett. : 273 -276.

    • Search Google Scholar
  • Murata, K., Saikusa, T., Fukuda, Y., et al.: Metabolism of 2-oxoaldehydes in yeasts. Possible role of glycolytic bypath as a detoxification system in L-threonine catabolism by Saccharomyces cerevisiae. Eur. J. Biochem., 1986, 157, 297–301.

    Fukuda Y. , 'Metabolism of 2-oxoaldehydes in yeasts. Possible role of glycolytic bypath as a detoxification system in L-threonine catabolism by Saccharomyces cerevisiae ' (1986 ) 157 Eur. J. Biochem. : 297 -301.

    • Search Google Scholar
  • Bechara, E. J., Dutra, F., Cardoso, V. E., et al.: The dual face of endogenous alpha-aminoketones: pro-oxidizing metabolic weapons. Comp. Biochem. Physiol. C. Toxicol. Pharmacol., 2007, 146, 88–110.

    Cardoso V. E. , 'The dual face of endogenous alpha-aminoketones: pro-oxidizing metabolic weapons ' (2007 ) 146 Comp. Biochem. Physiol. C. Toxicol. Pharmacol. : 88 -110.

    • Search Google Scholar
  • Magyar, K., Mészáros, Z.: Semicarbazide-sensitive amine oxidase (SSAO): present and future. Inflammopharmacology, 2003, 11, 165–173.

    Mészáros Z. , 'Semicarbazide-sensitive amine oxidase (SSAO): present and future ' (2003 ) 11 Inflammopharmacology : 165 -173.

    • Search Google Scholar
  • Kalapos, M. P.: Methylglyoxal in living organisms. Chemistry, biochemistry, toxicology and biological implications. Toxicol. Lett., 1999, 110, 145–175.

    Kalapos M. P. , 'Methylglyoxal in living organisms. Chemistry, biochemistry, toxicology and biological implications ' (1999 ) 110 Toxicol. Lett. : 145 -175.

    • Search Google Scholar
  • Miyata, T., Kurokawa, K., van Ypersele de Strihou, C.: Advanced glycation and lipoxidation end products: Role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J. Am. Soc. Nephrol., 2000, 11, 1744–1752.

    van Ypersele de Strihou C. , 'Advanced glycation and lipoxidation end products: Role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism ' (2000 ) 11 J. Am. Soc. Nephrol. : 1744 -1752.

    • Search Google Scholar
  • Dakin, H. D., Dudley, H. W.: An enzyme concerned with the formation of hydroxy acids from ketotic aldehydes. J. Biol. Chem., 1913, 49, 502–506.

    Dudley H. W. , 'An enzyme concerned with the formation of hydroxy acids from ketotic aldehydes ' (1913 ) 49 J. Biol. Chem. : 502 -506.

    • Search Google Scholar
  • Lohmann, K.: Beitrag zur enzymatischen Umwandlung von synthetischen Methylglyoxal in Milchsaure. Biochem. Zeitschr., 1932, 254, 332–354.

    Lohmann K. , 'Beitrag zur enzymatischen Umwandlung von synthetischen Methylglyoxal in Milchsaure ' (1932 ) 254 Biochem. Zeitschr. : 332 -354.

    • Search Google Scholar
  • Thornalley, P. J.: The glyoxalase system: a new developments towards functional characterization of metabolic pathway fundamental to biological life. Biochem. J., 1990, 269, 1–11.

    Thornalley P. J. , 'The glyoxalase system: a new developments towards functional characterization of metabolic pathway fundamental to biological life ' (1990 ) 269 Biochem. J. : 1 -11.

    • Search Google Scholar
  • Talesa, V., Uotila, L., Koivusalo, M., et al.: Isolation of glyoxalase II from two different compartments of rat liver mitochondria. Kinetic and immunochemical characterization of the enzymes. Biochim. Biophys. Acta, 1989, 993, 7–11.

    Koivusalo M. , 'Isolation of glyoxalase II from two different compartments of rat liver mitochondria. Kinetic and immunochemical characterization of the enzymes ' (1989 ) 993 Biochim. Biophys. Acta : 7 -11.

    • Search Google Scholar
  • Vander Jagt, D. L., Robinson, B., Taylor, K. K., et al.: Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications. J. Biol. Chem., 1992, 267, 4364–4369.

    Taylor K. K. , 'Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications ' (1992 ) 267 J. Biol. Chem. : 4364 -4369.

    • Search Google Scholar
  • Argiles, J. M.: The oxidation of methylglyoxal by mammalian pyruvate dehydrogenase. Arch. Biochem. Biophys., 1989, 273, 238–244.

    Argiles J. M. , 'The oxidation of methylglyoxal by mammalian pyruvate dehydrogenase ' (1989 ) 273 Arch. Biochem. Biophys. : 238 -244.

    • Search Google Scholar
  • Vander Jagt, D. L., Hunsaker, L. A.: Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chem. Biol. Interact., 2003, 143–144, 341–351.

    Hunsaker L. A. , 'Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase ' (2003 ) 143–144 Chem. Biol. Interact. : 341 -351.

    • Search Google Scholar
  • Monder, C.: Alpha-keto aldehyde dehydrogenase, an enzyme that catalyzes the enzymic oxidation of methylglyoxal to pyruvate. J. Biol. Chem., 1967, 242, 4603–4609.

    Monder C. , 'Alpha-keto aldehyde dehydrogenase, an enzyme that catalyzes the enzymic oxidation of methylglyoxal to pyruvate ' (1967 ) 242 J. Biol. Chem. : 4603 -4609.

    • Search Google Scholar
  • Thornalley, P. J.: Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochem. J., 1988, 254, 751–755.

    Thornalley P. J. , 'Modification of the glyoxalase system in human red blood cells by glucose in vitro ' (1988 ) 254 Biochem. J. : 751 -755.

    • Search Google Scholar
  • Atkins, T. W., Thornalley, P. J.: Erythrocyte glyoxalase activity in genetically-obes (ob/ob) and streptozotocin diabetic mice. Diabetes Res., 1989, 11, 125–129.

    Thornalley P. J. , 'Erythrocyte glyoxalase activity in genetically-obes (ob/ob) and streptozotocin diabetic mice ' (1989 ) 11 Diabetes Res. : 125 -129.

    • Search Google Scholar
  • Beisswenger, P. J., Howell, S. K., Touchette, A. D.: Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes, 1999, 48, 198–202.

    Touchette A. D. , 'Metformin reduces systemic methylglyoxal levels in type 2 diabetes ' (1999 ) 48 Diabetes : 198 -202.

    • Search Google Scholar
  • Nemet, I., Turk, Z., Duvnjak, L., et al.: Humoral methylglyoxal level reflects glycemic fluctuation. Clin. Biochem., 2005, 38, 379–383.

    Duvnjak L. , 'Humoral methylglyoxal level reflects glycemic fluctuation ' (2005 ) 38 Clin. Biochem. : 379 -383.

    • Search Google Scholar
  • Thornalley, P. J., Hooper, N. I., Jennings, P. E., et al.: The human red blood cell glyoxalase system in diabetes mellitus. Diabetes Res. Clin. Pract., 1989, 7, 115–120.

    Jennings P. E. , 'The human red blood cell glyoxalase system in diabetes mellitus ' (1989 ) 7 Diabetes Res. Clin. Pract. : 115 -120.

    • Search Google Scholar
  • Kalapos, M. P.: Medical aspects of methylglyoxal metabolism. [A metilglioxál anyagcsere orvosi vonatkozásai]. Orv. Hetil., 1992, 133, 587–591. [Hungarian]

    Kalapos M. P. , 'Medical aspects of methylglyoxal metabolism. [A metilglioxál anyagcsere orvosi vonatkozásai] ' (1992 ) 133 Orv. Hetil. : 587 -591.

    • Search Google Scholar
  • Casazza, J. P., Felver, M. E., Veech, R. L.: The metabolism of acetone in rat. J. Biol. Chem., 1984, 259, 231–236.

    Veech R. L. , 'The metabolism of acetone in rat ' (1984 ) 259 J. Biol. Chem. : 231 -236.

  • Gonzalez, F. J.: The molecular biology of cytochrome P450s. Pharmacol. Rev., 1988, 40, 243–288.

    Gonzalez F. J. , 'The molecular biology of cytochrome P450s ' (1988 ) 40 Pharmacol. Rev. : 243 -288.

    • Search Google Scholar
  • Lyles, G. A.: Mammalian plasma and tissue-bound semicarba ide-sensitive amine oxidases: Biochemical, pharmacological and toxicological aspects. Int. J. Biochem. Cell Biol., 1996, 28, 259–274.

    Lyles G. A. , 'Mammalian plasma and tissue-bound semicarba ide-sensitive amine oxidases: Biochemical, pharmacological and toxicological aspects ' (1996 ) 28 Int. J. Biochem. Cell Biol. : 259 -274.

    • Search Google Scholar
  • Yu, P. H., Zuo, D. M.: Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia, 1997, 40, 1243–1250.

    Zuo D. M. , 'Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications ' (1997 ) 40 Diabetologia : 1243 -1250.

    • Search Google Scholar
  • Baynes, J. W., Thorpe, S. R.: Glycoxidation and lipoxidation in atherogenesis. Free Radic. Biol. Med., 2000, 28, 1708–1716.

    Thorpe S. R. , 'Glycoxidation and lipoxidation in atherogenesis ' (2000 ) 28 Free Radic. Biol. Med. : 1708 -1716.

    • Search Google Scholar
  • Cecchi, C., Fiorillo, C., Sorbi, S., et al.: Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer’s patients. Free Radic. Biol. Med., 2002, 33, 1372–1379.

    Sorbi S. , 'Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer’s patients ' (2002 ) 33 Free Radic. Biol. Med. : 1372 -1379.

    • Search Google Scholar
  • Vander Jagt, D. L., Hunsaker, L. A., Vander Jagt, T. J., et al.: Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes. Biochem. Pharmacol., 1997, 53, 1133–1140.

    Jagt T. J. , 'Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes ' (1997 ) 53 Biochem. Pharmacol. : 1133 -1140.

    • Search Google Scholar
  • Lo, T. W., Westwood, M. E., McLellan, A. C., et al.: Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin. J. Biol. Chem., 1994, 269, 32299–32305.

    McLellan A. C. , 'Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin ' (1994 ) 269 J. Biol. Chem. : 32299 -32305.

    • Search Google Scholar
  • Thornalley, P. J.: Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems – role in ageing and disease. Drug Metabol. Drug Interact., 2008, 23, 125–150.

    Thornalley P. J. , 'Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems – role in ageing and disease ' (2008 ) 23 Drug Metabol. Drug Interact. : 125 -150.

    • Search Google Scholar
  • Goh, S. Y., Cooper, M. E.: The role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. Metab., 2008, 93, 1143–1152.

    Cooper M. E. , 'The role of advanced glycation end products in progression and complications of diabetes ' (2008 ) 93 J. Clin. Endocrinol. Metab. : 1143 -1152.

    • Search Google Scholar
  • Hammes, H. P., Alt, A., Niwa, T., et al.: Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia, 1999, 42, 728–736.

    Niwa T. , 'Differential accumulation of advanced glycation end products in the course of diabetic retinopathy ' (1999 ) 42 Diabetologia : 728 -736.

    • Search Google Scholar
  • Bucala, R., Vlassara, H.: Advanced glycosylation end products in diabetic renal and vascular disease. Am. J. Kidney Dis., 1995, 26, 875–888.

    Vlassara H. , 'Advanced glycosylation end products in diabetic renal and vascular disease ' (1995 ) 26 Am. J. Kidney Dis. : 875 -888.

    • Search Google Scholar
  • Bierhaus, A., Nawroth, P. P.: Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia, 2009, 52, 2251–2263.

    Nawroth P. P. , 'Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications ' (2009 ) 52 Diabetologia : 2251 -2263.

    • Search Google Scholar
  • Wang, X., Desai, K., Chang, T., et al.: Vascular methylglyoxal metabolism and the development of hypertension. J. Hypertens., 2005, 23, 1565–1573.

    Chang T. , 'Vascular methylglyoxal metabolism and the development of hypertension ' (2005 ) 23 J. Hypertens. : 1565 -1573.

    • Search Google Scholar
  • Ciechanowski, K., Kedzierska, K., Gołembiewska, E., et al.: Impaired synthesis is not the reason for decreased activity of extracellular superoxide dismutase in patients with diabetes. Arch. Med. Res., 2005, 36, 148–153.

    Gołembiewska E. , 'Impaired synthesis is not the reason for decreased activity of extracellular superoxide dismutase in patients with diabetes ' (2005 ) 36 Arch. Med. Res. : 148 -153.

    • Search Google Scholar
  • Kalapos, M. P.: Methylglyoxal toxicity in mammals. Toxicol. Lett., 1994, 73, 3–24.

    Kalapos M. P. , 'Methylglyoxal toxicity in mammals ' (1994 ) 73 Toxicol. Lett. : 3 -24.

  • Szent-Györgyi, A.: Growth and organisation. Biochem. J., 1966, 98, 641–644.

    Szent-Györgyi A. , 'Growth and organisation ' (1966 ) 98 Biochem. J. : 641 -644.

  • Murata-Kamiya, N., Kamiya, H., Kaji, H., et al.: Methylglyoxal induces G:C to C:G and G:C to T:A transversions in the supF gene on a shuttle vector plasmid replicated in mammalian cells. Mutat. Res., 2000, 468, 173–182.

    Kaji H. , 'Methylglyoxal induces G:C to C:G and G:C to T:A transversions in the supF gene on a shuttle vector plasmid replicated in mammalian cells ' (2000 ) 468 Mutat. Res. : 173 -182.

    • Search Google Scholar
  • Migliore, L., Barale, R., Bosco, E., et al.: Genotoxicity of methylglyoxal: cytogenetic damage in human lymphocytes in vitro and in intestinal cells of mice. Carcinogenesis, 1990, 11, 1503–1507.

    Bosco E. , 'Genotoxicity of methylglyoxal: cytogenetic damage in human lymphocytes in vitro and in intestinal cells of mice ' (1990 ) 11 Carcinogenesis : 1503 -1507.

    • Search Google Scholar
  • Murata-Kamiya, N., Kamiya, H.: Methylglyoxal, an endogenous aldehyde, crosslinks DNA polymerase and the substrate DNA. Nucleic Acids Res., 2001, 29, 3433–3438.

    Kamiya H. , 'Methylglyoxal, an endogenous aldehyde, crosslinks DNA polymerase and the substrate DNA ' (2001 ) 29 Nucleic Acids Res. : 3433 -3438.

    • Search Google Scholar
  • Ekelund, S., Nygren, P., Larsson, R.: Guanidino-containing drugs in cancer chemotherapy: biochemical and clinical pharmacology. Biochem. Pharmacol., 2001, 61, 1183–1193.

    Larsson R. , 'Guanidino-containing drugs in cancer chemotherapy: biochemical and clinical pharmacology ' (2001 ) 61 Biochem. Pharmacol. : 1183 -1193.

    • Search Google Scholar
  • Brownlee, M.: Biochemistry and molecular cell biology of diabetic complications. Nature, 2001, 414, 813–820.

    Brownlee M. , 'Biochemistry and molecular cell biology of diabetic complications ' (2001 ) 414 Nature : 813 -820.

    • Search Google Scholar
  • Finot, P. A.: Nonenzymatic browning products: physiologic effects and metabolic transit in relation to chemical structure. Diabetes, 1982, 31 (Suppl. 3), 22–28.

    Finot P. A. , 'Nonenzymatic browning products: physiologic effects and metabolic transit in relation to chemical structure ' (1982 ) 31 Diabetes : 22 -28.

    • Search Google Scholar
  • Thornalley, P. J., Lnagborg, A., Minhas, H. S.: Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J., 1999, 344, 109–116.

    Minhas H. S. , 'Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose ' (1999 ) 344 Biochem. J. : 109 -116.

    • Search Google Scholar
  • Shinohara, M., Thornalley, P. J., Giardino, I., et al.: Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J. Clin. Invest., 1998, 101, 1142–1147.

    Giardino I. , 'Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis ' (1998 ) 101 J. Clin. Invest. : 1142 -1147.

    • Search Google Scholar
  • Kilhovd, B. K., Berg, T. J., Birkeland, K. I., et al.: Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care, 1999, 22, 1543–1548.

    Birkeland K. I. , 'Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease ' (1999 ) 22 Diabetes Care : 1543 -1548.

    • Search Google Scholar
  • Kunt, T., Forst, T., Wilhelm, A., et al.: Alpha-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products. Clin. Sci. (Lond), 1999, 96, 75–82.

    Wilhelm A. , 'Alpha-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products ' (1999 ) 96 Clin. Sci. (Lond) : 75 -82.

    • Search Google Scholar
  • Bucala, R., Makita, Z., Vega, G., et al.: Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc. Natl. Acad. Sci., 1994, 91, 9441–9445.

    Vega G. , 'Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency ' (1994 ) 91 Proc. Natl. Acad. Sci. : 9441 -9445.

    • Search Google Scholar
  • Golej, J., Hoeger, H., Radner, W., et al.: Oral administration of methylglyoxal leads to kidney collagen accumulation in the mouse. Life Sci., 1998, 63, 801–807.

    Radner W. , 'Oral administration of methylglyoxal leads to kidney collagen accumulation in the mouse ' (1998 ) 63 Life Sci. : 801 -807.

    • Search Google Scholar
  • Tan, A. L., Sourris, K. C., Harcourt, B. E., et al.: Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. Am. J. Physiol. Renal. Physiol., 2010, 298, 763–770.

    Harcourt B. E. , 'Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy ' (2010 ) 298 Am. J. Physiol. Renal. Physiol. : 763 -770.

    • Search Google Scholar
  • Karachalias, N., Babaei-Jadidi, R., Ahmed, N., et al.: Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. Biochem. Soc. Trans., 2003, 31, 1423–5142.

    Ahmed N. , 'Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats ' (2003 ) 31 Biochem. Soc. Trans. : 1423 -5142.

    • Search Google Scholar
  • Stitt, A. W.: Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br. J. Ophthalmol., 2001, 85, 746–753.

    Stitt A. W. , 'Advanced glycation: an important pathological event in diabetic and age related ocular disease ' (2001 ) 85 Br. J. Ophthalmol. : 746 -753.

    • Search Google Scholar
  • Pi, J., Bai, Y., Zhang, Q., et al.: Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes, 2007, 56, 1783–1791.

    Zhang Q. , 'Reactive oxygen species as a signal in glucose-stimulated insulin secretion ' (2007 ) 56 Diabetes : 1783 -1791.

    • Search Google Scholar
  • Sheader, E. A., Benson, R. S., Best, L.: Cytotoxic action of methylglyoxal on insulin-secreting cells. Biochem. Pharmacol., 2001, 61, 1381–1386.

    Best L. , 'Cytotoxic action of methylglyoxal on insulin-secreting cells ' (2001 ) 61 Biochem. Pharmacol. : 1381 -1386.

    • Search Google Scholar
  • Jia, X., Olson, D. J., Ross, A. R., et al.: Structural and functional changes in human insulin induced by methylglyoxal. FASEB J., 2006, 20, 1555–1557.

    Ross A. R. , 'Structural and functional changes in human insulin induced by methylglyoxal ' (2006 ) 20 FASEB J. : 1555 -1557.

    • Search Google Scholar
  • Riboulet-Chavey, A., Pierron, A., Durand, I., et al.: Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species. Diabetes, 2006, 55, 1289–1299.

    Durand I. , 'Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species ' (2006 ) 55 Diabetes : 1289 -1299.

    • Search Google Scholar
  • Williamson, J. R., Chang, K., Frangos, M., et al.: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes, 1993, 42, 801–813.

    Frangos M. , 'Hyperglycemic pseudohypoxia and diabetic complications ' (1993 ) 42 Diabetes : 801 -813.

    • Search Google Scholar
  • Beisswenger, P. J., Drummond, K. S., Nelson, R. G., et al.: Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes, 2005, 54, 3274–3281.

    Nelson R. G. , 'Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress ' (2005 ) 54 Diabetes : 3274 -3281.

    • Search Google Scholar
  • Lee, C., Yim, M. B., Chock, P. B., et al.: Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation. J. Biol. Chem., 1998, 273, 25272–25278.

    Chock P. B. , 'Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation ' (1998 ) 273 J. Biol. Chem. : 25272 -25278.

    • Search Google Scholar
  • Rosca, M. G., Mustata, T. G., Kinter, M. T., et al.: Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am. J. Physiol. Renal. Physiol., 2005, 289, F420–F430.

    Kinter M. T. , 'Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation ' (2005 ) 289 Am. J. Physiol. Renal. Physiol. : F420 -F430.

    • Search Google Scholar
  • Tan, A. L., Forbes, J. M., Cooper, M. E.: AGE, RAGE, and ROS in diabetic nephropathy. Semin. Nephrol., 2007, 27, 130–143.

    Cooper M. E. , 'AGE, RAGE, and ROS in diabetic nephropathy ' (2007 ) 27 Semin. Nephrol. : 130 -143.

    • Search Google Scholar
  • Thornalley, P. J., McLellan, A. C., Lo, T. W., et al.: Negative association between erythrocyte reduced glutathione concentration and diabetic complications. Clin. Sci. (Lond), 1996, 91, 575–582.

    Lo T. W. , 'Negative association between erythrocyte reduced glutathione concentration and diabetic complications ' (1996 ) 91 Clin. Sci. (Lond) : 575 -582.

    • Search Google Scholar
  • Chang, K. C., Paek, K. S., Kim, H. J., et al.: Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol. Pharmacol., 2002, 61, 1184–1191.

    Kim H. J. , 'Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes ' (2002 ) 61 Mol. Pharmacol. : 1184 -1191.

    • Search Google Scholar
  • Du, J., Cai, S., Suzuki, H., et al.: Involvement of MEKK1/ERK/P21Waf1/Cip1 signal transduction pathway in inhibition of IGF-I-mediated cell growth response by methylglyoxal. J. Cell. Biochem., 2003, 88, 1235–1246.

    Suzuki H. , 'Involvement of MEKK1/ERK/P21Waf1/Cip1 signal transduction pathway in inhibition of IGF-I-mediated cell growth response by methylglyoxal ' (2003 ) 88 J. Cell. Biochem. : 1235 -1246.

    • Search Google Scholar
  • Fan, X., Subramaniam, R., Weiss, M. F., et al.: Methylglyoxal-bovine serum albumin stimulates tumor necrosis factor alpha secretion in RAW 264.7 cells through activation of mitogen-activating protein kinase, nuclear factor kappaB and intracellular reactive oxygen species formation. Arch. Biochem. Biophys., 2003, 409, 274–286.

    Weiss M. F. , 'Methylglyoxal-bovine serum albumin stimulates tumor necrosis factor alpha secretion in RAW 264.7 cells through activation of mitogen-activating protein kinase, nuclear factor kappaB and intracellular reactive oxygen species formation ' (2003 ) 409 Arch. Biochem. Biophys. : 274 -286.

    • Search Google Scholar
  • Caldwell, R. B.: Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr. Drug Targets, 2005, 6, 511–5124.

    Caldwell R. B. , 'Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress ' (2005 ) 6 Curr. Drug Targets : 511 -5124.

    • Search Google Scholar
  • Wilson, A. F., Elston, R. C., Tran, L. D., et al.: Use of the robust sib-pair method to screen for single-locus, multiple-locus, and pleiotropic effects: application to traits related to hypertension. Am. J. Hum. Genet., 1991, 48, 862–872.

    Tran L. D. , 'Use of the robust sib-pair method to screen for single-locus, multiple-locus, and pleiotropic effects: application to traits related to hypertension ' (1991 ) 48 Am. J. Hum. Genet. : 862 -872.

    • Search Google Scholar
  • Shinohara, M., Thornalley, P. J., Giardino, I., et al.: Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J. Clin. Invest., 1998, 101, 1142–1147.

    Giardino I. , 'Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis ' (1998 ) 101 J. Clin. Invest. : 1142 -1147.

    • Search Google Scholar
  • Rabbani, N., Thornalley, P. J.: Glyoxalase in diabetes, obesity and related disorders. Semin. Cell Dev. Biol., 2011, 22, 309–317.

    Thornalley P. J. , 'Glyoxalase in diabetes, obesity and related disorders ' (2011 ) 22 Semin. Cell Dev. Biol. : 309 -317.

    • Search Google Scholar
  • Bierhaus, A., Humpert, P. M., Morcos, M., et al.: Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med., 2005, 83, 876–886.

    Morcos M. , 'Understanding RAGE, the receptor for advanced glycation end products ' (2005 ) 83 J. Mol. Med. : 876 -886.

    • Search Google Scholar
  • Nagao, M., Fujita, Y., Sugimura, T., et al.: Methylglyoxal in beverages and foods: its mutagenicity and carcinogenicity. IARC Sci. Publ., 1986, 70, 283–291.

    Sugimura T. , 'Methylglyoxal in beverages and foods: its mutagenicity and carcinogenicity ' (1986 ) 70 IARC Sci. Publ. : 283 -291.

    • Search Google Scholar
The author instructions are available in PDF.
Instructions for Authors in Hungarian HERE.
Mendeley citation style is available HERE.

Főszerkesztő - Editor-in-Chief:
 
Zoltán PAPP (professor emeritus, Semmelweis Egyetem, Szülészeti és Nőgyógyászati Klinika, Budapest)

Read the professional career of Zoltán PAPP HERE.

All scientific publications of Zoltán PAPP are collected in the Hungarian Scientific Bibliography.

Főszerkesztő-helyettesek - Assistant Editors-in-Chief: 

  • Erzsébet FEHÉR (professor emeritus, Semmelweis Egyetem, Anatómiai, Szövet- és Fejlődéstani Intézet)
  • Krisztina HAGYMÁSI (egyetemi docens, Semmelweis Egyetem, I. Sebészeti és Intervenciós Gasztroenterológiai Klinika, Budapest)

Főmunkatársak - Senior Editorial Specialists:

  • László KISS (a Debreceni Egyetem habilitált doktora)
  • Gabriella LENGYEL (ny. egyetemi docens, Semmelweis Egyetem, I. Sebészeti és Intervenciós Gasztroenterológiai Klinika, Budapest)
  • Alajos PÁR (professor emeritus, Pécsi Tudományegyetem, I. Belgyógyászati Klinika)

 A Szerkesztőbizottság tagjai – Members of the Editorial Board:

  • Péter ANDRÉKA (főigazgató, Gottsegen György Országos Kardiovaszkuláris Intézet, Nemzeti Szívinfartkus Regiszter, Budapest)
  • Géza ÁCS Jr. (egyetemi tanár Floridában)
  • Csaba BALÁZS (egyetemi tanár, Budai Endokrinközpont, Budapest)
  • Péter BENCSIK (volt folyóirat-kiadás vezető, Akadémiai Kiadó, Budapest)
  • Zoltán BENYÓ (egyetemi tanár, Semmelweis Egyetem, Transzlációs Medicina Intézet, Budapest)
  • Dániel BERECZKI (egyetemi tanár, Semmelweis Egyetem, Neurológiai Klinika, Budapest)
  • Anna BLÁZOVICS (professor emeritus, Semmelweis Egyetem, Farmakognóziai Intézet, Budapest)
  • Elek DINYA (professor emeritus, biostatisztikus, Semmelweis Egyetem, Budapest)
  • Attila DOBOZY (professor emeritus, Szegedi Tudományegyetem, Bőrgyógyászati Klinika, Szeged)
  • András FALUS (professor emeritus, Semmelweis Egyetem, Genetikai, Sejt- és Immunbiológiai Intézet, Budapest)
  • Csaba FARSANG (egyetemi tanár, Szent Imre Oktató Kórház, Belgyógyászati Osztály, Budapest)
  • János FAZAKAS (egyetemi docens, Semmelweis Egyetem, Transzplantációs és Sebészeti Klinika, Budapest)
  • Béla FÜLESDI (egyetemi tanár, Debreceni Egyetem, Aneszteziológiai és Intenzív Terápiás Klinika, Debrecen)
  • Beáta GASZTONYI (egyetemi magántanár, kórházi főorvos, Zala Megyei Kórház, Belgyógyászat, Zalaegerszeg)
  • István GERGELY (egyetemi docens, Marosvásárhelyi Orvosi és Gyógyszerészeti Egyetem, Románia)
  • Judit GERVAIN (osztályvezető főorvos, Fejér Megyei Szent György Kórház, Belgyógyászat, Székesfehérvár)
  • Béla GÖMÖR (professor emeritus, Budai Irgalmasrendi Kórház, Reumatológiai Osztály, Budapest)
  • László GULÁCSI (egyetemi tanár, Óbudai Egyetem, Egészségügyi Közgazdaságtan Tanszék, Budapest)
  • János HANKISS (professor emeritus, Markusovszky Lajos Oktató Kórház, Belgyógyászati Osztály, Szombathely)
  • Örs Péter HORVÁTH (professor emeritus, Pécsi Tudományegyetem, Sebészeti Klinika, Pécs)
  • Béla HUNYADY (egyetemi tanár, Somogy Megyei Kaposi Mór Kórház, Belgyógyászat, Kaposvár)
  • Péter IGAZ (egyetemi tanár, Semmelweis Egyetem, Belgyógyászati és Onkológiai Klinika, Budapest)
  • Ferenc JAKAB (c. egyetemi tanár, Uzsoki Utcai Kórház, Sebészet, Budapest)
  • András JÁNOSI (c. egyetemi tanár, Gottsegen György Országos Kardiovaszkuláris Intézet, Nemzeti Szívinfartkus Regiszter, Budapest)
  • György JERMENDY (egyetemi tanár, Bajcsy-Zsilinszky Kórház, Belgyógyászat, Budapest)
  • László KALABAY (egyetemi tanár, Semmelweis Egyetem, Családorvosi Tanszék, Budapest)
  • János KAPPELMAYER (egyetemi tanár, Debreceni Egyetem, Laboratóriumi Medicina Intézet, Debrecen)
  • Éva KELLER (ny. egyetemi tanár, Semmelweis Egyetem, Igazságügyi és Biztosítás-orvostani Intézet, Budapest)
  • Mátyás KELTAI (ny. egyetemi docens, Gottsegen György Országos Kardiovaszkuláris Intézet, Nemzeti Szívinfartkus Regiszter, Budapest)
  • András KISS (egyetemi tanár, Semmelweis Egyetem, II. Patológiai Intézet, Budapest)
  • László KÓBORI (egyetemi tanár, Semmelweis Egyetem, Transzplantációs és Sebészeti Klinika, Budapest)
  • Lajos KULLMANN (ny. egyetemi tanár, Országos Rehabilitációs Intézet, Budapest)
  • Emese MEZŐSI (egyetemi tanár, Pécsi Tudományegyetem, I. Belgyógyászati Klinika, Pécs)
  • József MOLNÁR (professor emeritus, Szegedi Tudományegyetem, Mikrobiológiai és Immunológiai Intézet, Szeged)
  • Péter MOLNÁR (professor emeritus, Debreceni Egyetem, Magatartástudományi Intézet, Debrecen)
  • Györgyi MŰZES (egyetemi docens, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Bálint NAGY (egyetemi tanár, Debreceni Egyetem, Humángenetikai Tanszék, Debrecen)
  • Endre NAGY (egyetemi tanár, Debreceni Egyetem, Belgyógyászati Intézet, Debrecen) 
  • Péter NAGY (egyetemi tanár, Semmelweis Egyetem, I. Patológiai és Kísérleti Rákkutató Intézet, Budapest)
  • Viktor NAGY (főorvos, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Zoltán Zsolt NAGY (egyetemi tanár, Semmelweis Egyetem, Szemészeti Klinika, Budapest)
  • Balázs NEMES (egyetemi docens, Debreceni Egyetem, Transzplantációs Tanszék, Debrecen)
  • Attila PATÓCS (tudományos főmunkatárs, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Gabriella PÁR (egyetemi docens, Pécsi Tudományegyetem, I. Belgyógyászati Klinika)
  • György PFLIEGLER (egyetemi tanár, Debreceni Egyetem, Ritka Betegségek Tanszéke, Debrecen)
  • István RÁCZ (egyetemi tanár, főorvos, Petz Aladár Megyei Oktató Kórház, Belgyógyászat, Győr)
  • Imre ROMICS (professor emeritus, Semmelweis Egyetem, Urológiai Klinika, Budapest)
  • László Jr. ROMICS (Angliában dolgozik) 
  • Imre RURIK (egyetemi tanár, Debreceni Egyetem, Családorvosi és Foglalkozás-egészségügyi Tanszék, Debrecen)
  • Zsuzsa SCHAFF (professor emeritus, Semmelweis Egyetem, II. Patológiai Intézet, Budapest)
  • Péter SCHMIDT (házi gyermekorvos, Győr)
  • Kornél SIMON (ny. osztályvezető főorvos, Siófoki Kórház, Belgyógyászat, Siófok)
  • Gábor SIMONYI (vezető főorvos, Szent Imre Kórház, Anyagcsere Központ, Budapest)
  • Gábor Márk SOMFAI (egyetemi docens, Semmelweis Egyetem, Szemészeti Klinika, Budapest)
  • Anikó SOMOGYI (ny. egyetemi tanár, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Péter SÓTONYI (professor emeritus, Semmelweis Egyetem, Igazságügyi és Biztosítás-orvostani Intézet, Budapest)
  • Péter Jr. SÓTONYI (egyetemi tanár, Semmelweis Egyetem, Városmajori Szív- és Érsebészeti Klinika, Budapest)
  • Ildikó SÜVEGES (professor emeritus, Semmelweis Egyetem, Szemészeti Klinika, Budapest)
  • György SZABÓ (professor emeritus, Semmelweis Egyetem, Arc-Állcsont-Szájsebészeti és Fogászati Klinika, Budapest)
  • Ferenc SZALAY (professor emeritus, Semmelweis Egyetem, Belgyógyászati és Onkológiai Klinika, Budapest)
  • Miklós SZENDRŐI (professor emeritus, Semmelweis Egyetem, Ortopédiai Klinika, Budapest)
  • István SZILVÁSI (egyetemi tanár, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Miklós TÓTH (egyetemi tanár, Semmelweis Egyetem, Belgyógyászati és Onkológiai Klinika, Budapest)
  • László TRINGER (professor emeritus, Semmelweis Egyetem, Pszichiátriai és Pszichoterápiás Klinika, Budapest)
  • Tivadar TULASSAY (professor emeritus, Semmelweis Egyetem, I. Gyermekgyógyászati Klinika, Budapest)
  • Zsolt TULASSAY (professor emeritus, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Lívia VASAS (ny. könyvtárigazgató, Semmelweis Egyetem, Központi Könyvtár, Budapest)
  • Barna VÁSÁRHELYI (egyetemi tanár, Semmelweis Egyetem, Laboratóriumi Medicina Intézet, Budapest)
  • László VÉCSEI (professor emeritus, Szegedi Tudományegyetem, Neurológiai Klinika, Szeged)
  • Gábor WINKLER (egyetemi tanár, Szent János Kórház, Belgyógyászati Osztály, Budapest)

Nemzetközi szerkesztőbizottság - International Editorial Board:

  • Elnök/President Péter SÓTONYI (Budapest)
  • Ernest ADEGHATE (Al Ain)
  • Ferenc ANTONI (Edinburgh)
  • Maciej BANACH (Łódź)
  • Klára BERENCSI (Rosemont)
  • Angelo BIGNAMINI (Milano)
  • Anupam BISHAYEE (Signal Hill)
  • Hubert E. BLUM (Freiburg)
  • G. László BOROS (Los Angeles)
  • Frank A. CHERVENAK (New York)
  • Meinhard CLASSEN (München)
  • József DÉZSY (Wien)
  • Peter ECKL (Salzburg)
  • Péter FERENCI (Wien)
  • Madelaine HAHN (Erlangen)
  • S. Tamás ILLÉS (Bruxelles)
  • Michael KIDD (Toronto)
  • Andrzej KOKOSZKA (Warsaw)
  • Márta KORBONITS (London)
  • Asim KURJAK (Zagreb)
  • Manfred MAIER (Wien)
  • Neil MCINTYRE (London)
  • Lajos OKOLICSÁNYI (Padova)
  • Amado Salvador PENA (Amsterdam)
  • Guliano RAMADORI (Goettingen)
  • Olivér RÁCZ (Košice)
  • Roberto ROMERO (Detroit)
  • Rainer SCHÖFL (Linz)
  • Zvi VERED (Tel Aviv)
  • Josef VESELY (Olomouc)
  • Ákos ZAHÁR (Hamburg)

Akadémiai Kiadó Zrt. 1117 Budapest
Budafoki út 187-189.
A épület, III. emelet
Phone: (+36 1) 464 8235
Email: orvosihetilap@akademiai.hu

2020  
Total Cites 1277
WoS
Journal
Impact Factor
0,540
Rank by Medicine, General & Internal 155/169 (Q4)
Impact Factor  
Impact Factor 0,310
without
Journal Self Cites
5 Year 0,461
Impact Factor
Journal  0,17
Citation Indicator  
Rank by Journal  Medicine, General & Internal 203/313 (Q4)
Citation Indicator   
Citable 261
Items
Total 229
Articles
Total 32
Reviews
Scimago 21
H-index
Scimago 0,176
Journal Rank
Scimago Medicine (miscellaneous) Q4
Quartile Score  
Scopus 921/1187=0,8
Scite Score  
Scopus General Medicine 494/793 (Q3)
Scite Score Rank  
Scopus 0,283
SNIP  
Days from  28
submission  
to acceptance  
Days from  114
acceptance  
to publication  
Acceptance 72%
Rate

2019  
Total Cites
WoS
1 085
Impact Factor 0,497
Impact Factor
without
Journal Self Cites
0,212
5 Year
Impact Factor
0,396
Immediacy
Index
0,126
Citable
Items
247
Total
Articles
176
Total
Reviews
71
Cited
Half-Life
6,1
Citing
Half-Life
7,3
Eigenfactor
Score
0,00071
Article Influence
Score
0,045
% Articles
in
Citable Items
71,26
Normalized
Eigenfactor
0,08759
Average
IF
Percentile
10,606
Scimago
H-index
20
Scimago
Journal Rank
0,176
Scopus
Scite Score
864/1178=0,4
Scopus
Scite Score Rank
General Medicine 267/529 (Q3)
Scopus
SNIP
0,254
Acceptance
Rate
73%

 

Orvosi Hetilap
Publication Model Hybrid
Submission Fee none
Article Processing Charge 900 EUR/article
Printed Color Illustrations 20 EUR (or 5000 HUF) + VAT / piece
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 844 EUR / 1124 USD
Print + online subscription: 956 EUR / 1326 USD
Subscription fee 2022 Online subsscription: 858 EUR / 1157 USD
Print + online subscription: 975 EUR / 1352 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Orvosi Hetilap
Language Hungarian
Size A4
Year of
Foundation
1857
Publication
Programme
2021 Volume 162
Volumes
per Year
1
Issues
per Year
52
Founder Markusovszky Lajos Alapítvány -- Lajos Markusovszky Foundation
Founder's
Address
H-1088 Budapest, Szentkriályi u. 46.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0030-6002 (Print)
ISSN 1788-6120 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2021 0 6 13
Jul 2021 0 17 25
Aug 2021 0 24 21
Sep 2021 0 10 16
Oct 2021 0 14 33
Nov 2021 0 11 39
Dec 2021 0 0 0